Outcomes of Standard-Risk Multiple Myeloma Patients Who Undergo Upfront Autologous Hematopoietic Stem Cell Transplantation

Autor:	Pasvolsky, Oren 1, #, Marcoux, Curtis 2, #, Wang, Zhongya 3, Milton, Denái R. 3, Pal, Babar 4, Tanner, Mark R. 4, Bashir, Qaiser 4, Srour, Samer 4, Saini, Neeraj 4, Lin, Paul 4, Ramdial, Jeremy 4, Nieto, Yago 4, Tang, Guilin 5, Syed, Naureen 4, Aljawai, Yosra 4, Lee, Hans C. 1, Patel, Krina K. 1, Becnel, Melody R. 1, Ye, Christine 1, Kebriaei, Partow 4, Thomas, Sheeba K. 1, Orlowski, Robert Z. 1, 6, Champlin, Richard E. 4, Shpall, Elizabeth J. 4, Qazilbash, Muzaffar H. 4, ⁎
Zdroj:	In Transplantation and Cellular Therapy December 2024
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect